TRML
Tourmaline Bio
TRML
TRML
Delisted
TRML was delisted on the 27th of October, 2025.
107 hedge funds and large institutions have $364M invested in Tourmaline Bio in 2025 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
4.06% more ownership
Funds ownership: 89.17% → 93.23% (+4.1%)
10% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 31
21% less capital invested
Capital invested by funds: $464M → $364M (-$99.4M)
Holders
107
Holding in Top 10
6
Calls
$3.09M
Puts
$93K
Top Buyers
| 1 | +$13.8M | |
| 2 | +$11.6M | |
| 3 | +$9.02M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.17M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$3.08M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$11.1M | |
| 3 | -$5.34M | |
| 4 |
SC
Stempoint Capital
New York
|
-$2.56M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.52M |
